Screening Value of Lung Ultrasound in Connective Tissue Disease Related Interstitial Lung Disease.

Yupeng Huang,Tao Liu,Songya Huang,Li Qiu,Fengming Luo,Geng Yin,Qibing Xie
DOI: https://doi.org/10.1016/j.hrtlng.2022.09.011
IF: 3.149
2022-01-01
Heart & Lung
Abstract:Background: Interstitial lung disease (ILD) is a common pulmonary complication of connective tissue disease (CTD) that can lead to poor quality of life and prognosis. Objectives: To explore the screening value of lung ultrasound (LUS) for connective tissue disease-associated interstitial lung disease (CTD-ILD). Methods: Data of patients with CTD were collected, and each patient underwent LUS, high-resolution computed tomography (HRCT), and pulmonary function tests. Considering HRCT is the gold standard for diagnosing CTD-ILD, patients were divided into CTD-ILD and CTD-non-ILD groups. The LUS and HRCT results were assessed using semiquantitative and Warrick scores, respectively. Pulmonary function results were also collected. Receiver operating characteristic (ROC) curves were used to evaluate the accuracy of LUS diagnosis. Spearman correlation analysis was used to analyze the correlation between LUS, HRCT, and lung function indices. Results: A total of 88 patients (65 with CTD-ILD and 23 with CTD-non-ILD) were included in this study. The sensitivity and specificity of LUS for the diagnosis of CTD-ILD were 86.60% and 82.60%, respectively, which was consistent with the HRCT results (P < 0.05). The LUS results (total number of B-lines, frequency of B-line, pleural thickness, and pleural-line irregularity) were positively correlated with the HRCT Warrick score (r = 0.77, 0.76, 0.65 and 0.71, P < 0.05). Conclusions: LUS may be a promising tool for screening patients with CTD-ILD. (C) 2022 The Author(s). Published by Elsevier Inc.
What problem does this paper attempt to address?